Global Alpha Emitters Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

The global market for alpha emitters has been estimated at $XX million for the year 2018 and is projected to reach $XX million by 2024 at a CAGR of XX% during the forecast period 2018 to 2024. Alpha emitters are a type of radioactive substances that decay after emitting alpha particles. Alpha emitter radionuclide has been considered to be a new approach to treat many cancer types. Alpha-particles offer specific tumour cell killing actions causing less damage to surrounding healthy tissues than beta-emitters, and this potential has caught market attention.

Global Alpha Emitters Market Share:

Alpha emitter therapy holds a great promise when compared to chemotherapy as targeted alpha therapy allows easy discrimination between the healthy cells and cancer cells. The end-users of this market are usually Hospital, Imaging centres and research laboratories.

Global Alpha Emitters Market Size:

The number of therapeutic procedures recorded in North America, Europe and Asia-Pacific is 298, 22206, and 271262 respectively for the year 2018. Country-wise, US has 262 therapeutic procedures. Developing countries like India hold strong market potential, accounting for 7488 therapeutic procedures.

Global Alpha Emitters Market Growth:

The drivers contributing to the growth of the market are increasing incidences of cardiac & cancer ailments, raised awareness about the potential benefits of targeted alpha therapy and increasing availability of radiopharmaceuticals.

Global Alpha Emitters Market Industry Analysis:

Alpha Emitters market can be segmented by Radionuclide Types which include Terbium (Tb-149), Astatine (At-211), Bismuth (Bi-212), Bismuth (Bi-213), Actinium (Ac-225), Radium (Ra-223), Lead (Pb-212) and others. Based on Medical Application, the market is segmented into Endocrine Tumors, Lymphoma, Bone Metastasis, Thyroid, Ovarian Cancer,   Pancreatic Cancer, Melanoma, etc.

Global Alpha Emitters Market Outlook:

Shorter life of radiopharmaceuticals need for high capital investment, stringent regulatory framework and reimbursement issues are the primary factors impacting the Alpha Emitters market growth.

Global Alpha Emitters Market Trends:

Nordion, Bruce Power and Cameco work together to provide a reliable supply of Cobalt-60. New Research by Cardinal Health Specialty Solutions Explores Oncologists’ Views on Emerging Therapies.

Global Alpha Emitters Market Research report includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Nordion, Inc.
• Cardinal Health, Inc.
• AlphaTau
• Lantheus Medical Imaging
• Plexus NSD